CHRONIC HEPAITITIS B
Clinical trials for CHRONIC HEPAITITIS B explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPAITITIS B trials appear
Sign up with your email to follow new studies for CHRONIC HEPAITITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Silencing shot aims to quiet hepatitis b for good
Disease control Recruiting nowThis early-stage trial tests a new therapy called CRMA-1001, which uses epigenetic gene silencing to turn off the hepatitis B virus in the body. About 66 adults with chronic hepatitis B who are already on antiviral pills will receive one or more IV infusions of the therapy. The m…
Matched conditions: CHRONIC HEPAITITIS B
Phase: PHASE1, PHASE2 • Sponsor: nChroma Bio • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a shot keep hepatitis b away after 'Cure'? new trial aims to find out
Disease control Recruiting nowThis study tests whether hepatitis B immunoglobulin (HBIG) can help people with chronic hepatitis B stay virus-free after they've cleared the surface antigen (a key sign of cure). Researchers will give HBIG shots to 132 participants who already cleared the virus with standard the…
Matched conditions: CHRONIC HEPAITITIS B
Phase: EARLY_PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC